News
Diagnostics company Guardant Health (NASDAQ:GH) will be reporting earnings tomorrow after market hours. Here’s what you need ...
Analysts expect the New York-based company to report quarterly earnings at 68 cents per share, down from 82 cents per share ...
StockStory.org on MSN8d
3 Reasons to Sell GH and 1 Stock to Buy InsteadWhat a time it’s been for Guardant Health. In the past six months alone, the company’s stock price has increased by a massive ...
Guardant Health, Inc. (NASDAQ:GH) on Thursday announced a strategic collaboration with Pfizer, Inc. (NYSE:PFE) to support the ...
Precision oncology company Guardant Health has announced a strategic collaboration with Pfizer to support the development and ...
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Core Equity Strategy” first quarter 2025 investor ...
Guardant Health (GH) announced a strategic collaboration with Pfizer (PFE) to support the development and commercialization of Pfizer’s ...
Guardant Health, Inc. (NASDAQ:GH – Free Report) – Analysts at Leerink Partnrs decreased their Q3 2025 earnings per share estimates for shares of Guardant Health in a research report issued on ...
Pharmaceutical companies dominate the list of donors, which also includes HCA Healthcare, Centene, Molina Healthcare and the ...
Guardant Health Inc. advanced stock charts by Barron's. View GH historical stock data and compare to other stocks, and exchanges.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results